Concepedia

Jing Li

JL

Statistics

Publications

28

Citations

1.3K

H-Index

18

Active since

2008

Affiliations

The Barbara Ann Karmanos Cancer Institute(Current)

Wayne State University

Barrow Neurological Institute

University of Maryland, Baltimore

Yale Cancer Center

Jing Li is an author at The Barbara Ann Karmanos Cancer Institute specializing in oncology, pharmacology, and medicine.

ORCID

Publications per year

2008–2024

28

Publications

28

Oncometabolites suppress DNA repair by disrupting local chromatin signalling

Parker L. Sulkowski, Sebastian Oeck, Jonathan Dow et al. · Nature · 2020 · 310 citations · Full text

, , +14

Krebs-cycle-deficient hereditary cancer syndromes are defined by defects in homologous-recombination DNA repair

Parker L. Sulkowski, Ranjini K. Sundaram, Sebastian Oeck et al. · Nature Genetics · 2018 · 215 citations

, , +14

Protein Expression and Functional Relevance of Efflux and Uptake Drug Transporters at the Blood–Brain Barrier of Human Brain and Glioblastoma

Xun Bao, Jianmei Wu, Youming Xie et al. · Clinical Pharmacology & Therapeutics · 2019 · 88 citations · Full text

, , +17

Clinical Pharmacokinetics and Exposure‐Toxicity Relationship of a Folate‐<i>Vinca</i> Alkaloid Conjugate EC145 in Cancer Patients

Jing Li, Edward A. Sausville, Patrick Klein et al. · The Journal of Clinical Pharmacology · 2009 · 77 citations

, , +16

Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of the Combination of Sorafenib and Tanespimycin

Ulka N. Vaishampayan, Angelika M. Burger, Edward A. Sausville et al. · Clinical Cancer Research · 2010 · 63 citations · Full text

, , +15

1–5 of 28